SCHEMBL29625932

SCHEMBL29625932

COC(=O)c1cc(NC(=O)Nc2cccc(C)c2)ccc1Oc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.55
KMT2A Q03164 8/20 0.55
LMNA P02545 4/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
MAPT P10636 7/20 0.54
CASP3 P42574 1/20 0.54
SENP7 Q9BQF6 1/20 0.54
SENP6 Q9GZR1 1/20 0.54
HTT P42858 2/20 0.52
NPSR1 Q6W5P4 2/20 0.52
KDR P35968 2/20 0.52
PDGFRA P16234 1/20 0.52
ALDH1A1 P00352 3/20 0.51
CDK8 P49336 2/20 0.50
IMPDH2 P12268 1/20 0.50
POLB P06746 1/20 0.50
PKM P14618 1/20 0.50
GPR17 Q13304 1/20 0.49
MAPK1 P28482 3/20 0.49
SAE1 Q9UBE0 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23051387 1.00 MEN1 (0.55) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL6564434 0.91 MEN1 (0.65) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL23051388 0.90 NPSR1 (0.49) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL23051396 0.85 KMT2A (0.58) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL23051408 0.84 KMT2A (0.57) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL10192075 0.82 KMT2A (0.71) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL29625934 0.82 KMT2A (0.55) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL23041016 0.82 KMT2A (0.55) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL29250498 0.82 KDM4E (0.54) MEN1KMT2ASMN1; SMN2MAPTHTT
SCHEMBL23051397 0.81 MEN1 (0.52) MEN1KMT2ALMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114423743-A Triazine derivatives for the treatment of diseases associated with neurotrophic factors 阿泽克制药公司 2022-04-29 CN disclosed